- Home
- TNGX vs NUS Comparison
TNGX vs NUS Comparison
Compare TNGX & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- NUS
- Stock Information
- Founded
- TNGX 2014
- NUS 1984
- Country
- TNGX United States
- NUS United States
- Employees
- TNGX N/A
- NUS N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- NUS Other Pharmaceuticals
- Sector
- TNGX Health Care
- NUS Health Care
- Exchange
- TNGX Nasdaq
- NUS Nasdaq
- Market Cap
- TNGX 351.2M
- NUS 440.8M
- IPO Year
- TNGX N/A
- NUS 1996
- Fundamental
- Price
- TNGX $6.13
- NUS $8.65
- Analyst Decision
- TNGX Strong Buy
- NUS Hold
- Analyst Count
- TNGX 6
- NUS 2
- Target Price
- TNGX $12.20
- NUS $6.88
- AVG Volume (30 Days)
- TNGX 2.6M
- NUS 517.8K
- Earning Date
- TNGX 08-06-2025
- NUS 08-07-2025
- Dividend Yield
- TNGX N/A
- NUS 2.78%
- EPS Growth
- TNGX N/A
- NUS N/A
- EPS
- TNGX N/A
- NUS N/A
- Revenue
- TNGX $40,990,000.00
- NUS $1,679,268,000.00
- Revenue This Year
- TNGX N/A
- NUS N/A
- Revenue Next Year
- TNGX N/A
- NUS N/A
- P/E Ratio
- TNGX N/A
- NUS N/A
- Revenue Growth
- TNGX 10.09
- NUS N/A
- 52 Week Low
- TNGX $1.03
- NUS $5.32
- 52 Week High
- TNGX $12.02
- NUS $11.64
- Technical
- Relative Strength Index (RSI)
- TNGX 71.70
- NUS 55.13
- Support Level
- TNGX $5.75
- NUS $7.86
- Resistance Level
- TNGX $6.40
- NUS $9.50
- Average True Range (ATR)
- TNGX 0.48
- NUS 0.36
- MACD
- TNGX -0.04
- NUS 0.04
- Stochastic Oscillator
- TNGX 75.62
- NUS 55.47
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.